The main treatments used for SARS-CoV-2 patients
No Thumbnail Available
Date
2022-12-30
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
جامعة الوادي - University of Eloued
Abstract
As the COVID-19 pandemic continues to ravage the world and threaten people's lives, treating
infected patients effectively has been one of the top concerns for medical workers around the
world. Currently, no medication is recommended to treat COVID-19, and no cure is available.
Researchers are testing a variety of possible treatments. Several drugs are being researched in
different countries. Most are existing drugs that are being trialled against the virus.
Pharmaceuticals undergoing clinical trials to assess their safety and efficacy as potential
treatments for COVID-19, include the antiviral nucleotide analogue remdesivir, systemic
interferons and in particular interferon β-1a, the antiviral combination lopinavir/ritonavir, the
antimalarial chloroquine/hydroxychloroquine, and monoclonal antibodies against components
of the immune system such as interleukin-6 (IL-6) and IL-4. It is important that the potential
treatments are carefully assessed in randomised controlled trials.
Description
article
Keywords
SARS-CoV 2, Antivirals, Immunomodulators, Corticosteroid therapy, Plasma therapy.
Citation
.Djamila, MERGHACHE . The main treatments used for SARS-CoV-2 patients. Algerian Journal of Biosciences . Vol 03. N 02. 30/12/2022. University of Eloued .[Write down the date][Copy the download link ]